CRIS Current Research Information System

GRAMANTIERI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.066
EU - Europa 1.649
AS - Asia 376
AF - Africa 88
Continente sconosciuto - Info sul continente non disponibili 16
SA - Sud America 9
Totale 4.204
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.059
GB - Regno Unito 376
IT - Italia 348
SE - Svezia 251
DE - Germania 184
CN - Cina 182
IN - India 104
IE - Irlanda 85
CH - Svizzera 77
RU - Federazione Russa 65
FR - Francia 59
UA - Ucraina 58
VN - Vietnam 48
BG - Bulgaria 41
TG - Togo 40
ZA - Sudafrica 32
EE - Estonia 28
FI - Finlandia 23
JO - Giordania 21
EU - Europa 15
BE - Belgio 9
HR - Croazia 9
NL - Olanda 8
CA - Canada 6
EC - Ecuador 6
MK - Macedonia 6
NG - Nigeria 6
CI - Costa d'Avorio 5
PL - Polonia 5
RO - Romania 4
SC - Seychelles 4
AM - Armenia 3
GR - Grecia 3
LB - Libano 3
AT - Austria 2
BR - Brasile 2
DK - Danimarca 2
HK - Hong Kong 2
ID - Indonesia 2
JP - Giappone 2
MD - Moldavia 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
CU - Cuba 1
CZ - Repubblica Ceca 1
ES - Italia 1
IR - Iran 1
KE - Kenya 1
KR - Corea 1
LK - Sri Lanka 1
MY - Malesia 1
PE - Perù 1
SG - Singapore 1
TH - Thailandia 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 4.204
Salva come PNG Salva come JPEG
Città #
Southend 349
Fairfield 302
Chandler 214
Ashburn 184
Woodbridge 159
Houston 141
Wilmington 129
Seattle 125
Bologna 94
Princeton 88
Dublin 85
Ann Arbor 79
Cambridge 79
Bern 75
Sofia 41
Lomé 40
Dong Ket 35
Jacksonville 34
Westminster 34
Padova 32
Nanjing 29
Berlin 23
Helsinki 22
Amman 21
Beijing 20
Saint Petersburg 19
Jinan 18
New York 18
Hebei 17
San Diego 17
Florence 15
Milan 15
Turin 15
Boardman 14
Zhengzhou 13
Nanchang 11
Des Moines 10
Jiaxing 10
Pune 10
Bremen 9
Brussels 9
Shenyang 9
Bühl 8
Dearborn 8
Falls Church 8
Haikou 8
Medford 8
Mülheim 8
Norwalk 8
Changsha 7
Abeokuta 6
Chicago 6
Forlì 6
Quito 6
Skopje 6
Abidjan 5
Amsterdam 5
Mountain View 5
Tianjin 5
Toronto 5
Verona 5
Guangzhou 4
Medolla 4
Olalla 4
Philadelphia 4
Reggio Nell'emilia 4
Rome 4
Taizhou 4
Treviso 4
Boydton 3
Bucharest 3
Fuzhou 3
London 3
Los Angeles 3
L’Aquila 3
Mahé 3
Ningbo 3
Paris 3
Phoenix 3
Redmond 3
Russi 3
San Lazzaro di Savena 3
Serio 3
Taiyuan 3
Washington 3
Atlanta 2
Beverwijk 2
Bolzano 2
Busto Arsizio 2
Capua 2
Changchun 2
Chisinau 2
Costabissara 2
Dallas 2
Faenza 2
Hangzhou 2
Hong Kong 2
Kiev 2
Kuban 2
Mirano 2
Totale 2.896
Salva come PNG Salva come JPEG
Nome #
Circulating microRNAs, MIR-939, MIR-595, MIR-519d and MIR-494, identify cirrhotic patients with HCC 186
LncRNAs as novel players in hepatocellular carcinoma recurrence 134
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. 131
Oncogenic role of miR-483-3p at the IGF2/483 locus. 122
Corrigendum: Vidatox 30 CH has tumor activating effect in hepatocellular carcinoma (Scientific Reports (2017) 7 (44685) DOI: 10.1038/srep44685) 122
F.N.27 NOTCH SIGNALLING CONTROLS PROLIFERATION AND SENESCENCE OF HUMAN HEPATOCELLULAR CARCINOMA 121
In hepatocellular carcinoma miR-221 modulates sorafenib resistance through inhibition of caspase-3–mediated apoptosis 121
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 120
Molecular and proteomic insight into Notch1 characterization in hepatocellular carcinoma 113
MiR-122/Cyclin G1 Interaction Modulates p53 Activity and Affects Doxorubicin Sensitivity of Human Hepatocarcinoma Cells. 110
Targeting notch3 in hepatocellular carcinoma: Molecular mechanisms and therapeutic perspectives 110
Venom from Cuban Blue Scorpion has tumor activating effect in hepatocellular carcinoma 110
MiR-199-3p replacement affects E-cadherin expression through Notch1 targeting in hepatocellular carcinoma 108
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. 105
GADD45alpha expression in cirrhosis and hepatocellular carcinoma. Relationship with DNA-repair and proliferation. 102
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. 101
Different haemodynamic effects of a single dose of long-acting isosorbide-5-mononitrate in healthy subjects and patients with cirrhotic portal hypertension. 98
Tissue miRNA 483-3p expression predicts tumor recurrence after surgical resection in histologically advanced hepatocellular carcinomas 98
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. 94
p53/mdm2 feedback loop sustains miR-221 expression and dictates the response to anticancer treatments in hepatocellular carcinoma 94
MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma 93
Frequent aberrant methylation of the CDH4 gene promoter in human colorectal and gastric cancer. 92
MicroRNAs in Animal Models of HCC 92
T.N.28 P53 IS REGULATED BY NOTCH3 SIGNALLING VIA MDM2 IN HEPATOCELLULAR CARCINOMA 90
Significance of serum and hepatic microRNA-122 levels in patients with non-alcoholic fatty liver disease. 89
Improving accuracy in the diagnosis of small HCC (< 20 mm) on cirrhosis by a combined CT-MRI Ultrasound navigation system. Preliminary report of a work in progress. 89
TP53/MicroRNA interplay in hepatocellular carcinoma 86
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 83
Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin 83
Direct antiviral treatments for hepatitis c virus have off-target effects of oncologic relevance in hepatocellular carcinoma 80
null 77
MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches 76
Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma. 75
Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area 70
Notch3 inhibition enhances sorafenib cytotoxic efficacy by promoting GSK3b phosphorylation and p21 down-regulation in hepatocellular carcinoma. 69
Notch3 intracellular domain accumulates in HepG2 cell line. 68
Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma (Targeted Oncology, (2020), 15, 6, (773-785), 10.1007/s11523-020-00757-3) 67
Efficacy of superselective TACE in treatment of HCC 64
Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions 63
c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma 59
Hepatic cancer stem cells: Molecular mechanisms, therapeutic implications, and circulating biomarkers 57
Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma 54
Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study 53
MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma 52
MiR-122 targets serpinB3 and is involved in sorafenib resistance in hepatocellular carcinoma 50
MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma 39
Notch signaling regulation in HCC: From hepatitis virus to non‐coding rnas 35
Animal models of hepatocellular carcinoma prevention 28
Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research 27
miRNA Signature of Hepatocellular Carcinoma Vascularization: How the Controls Can Influence the Signature 26
MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma 24
Emerging role of microRNAs in the treatment of hepatocellular carcinoma 24
Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma 13
Laboratory signs of acute or recent cytomegalovirus infection are common in cirrhosis of the liver 12
Noncoding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response 9
MicroRNA as predictive biomarkers of treatment response to tyrosine kinase inhibitors in hepatocellular carcinoma: how much s missing? 8
Brivanib in combination with Notch3 silencing shows potent activity in tumour models 7
Pathophysiology roles and translational opportunities of miRNAs in hepatocellular carcinoma 4
Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma 4
Totale 4.391
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.986
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.986
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201948 0 0 0 0 0 0 0 0 0 0 19 29
2019/20201.062 143 22 7 53 99 115 137 151 154 83 50 48
2020/2021558 109 42 16 15 11 38 43 40 75 47 24 98
2021/2022976 55 44 60 86 74 47 19 96 36 84 253 122
2022/20231.084 99 121 62 123 65 93 21 57 192 28 76 147
2023/2024381 32 70 19 37 55 79 13 20 19 30 7 0
Totale 4.391